LC
IART icon

Lindbrook Capital’s Integra LifeSciences IART Stock Holding History

Lindbrook Capital’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$18K Buy
819
+13
+2% +$306 ﹤0.01% 1400
2024
Q4 		$18.3K Buy
806
+532
+194% +$11.6K ﹤0.01% 1333
2024
Q3 		$4.98K Sell
274
-638
-70% -$14.8K ﹤0.01% 2016
2024
Q2 		$26.6K Buy
912
+862
+1,724% +$25.6K ﹤0.01% 1085
2024
Q1 		$1.77K Sell
50
-7
-12% -$280 ﹤0.01% 2286
2023
Q4 		$2.48K Sell
57
-200
-78% -$7.87K ﹤0.01% 2194
2023
Q3 		$9.81K Buy
257
+135
+111% +$5.68K ﹤0.01% 1429
2023
Q2 		$5.02K Sell
122
-158
-56% -$7.6K ﹤0.01% 1805
2023
Q1 		$16.1K Buy
280
+12
+4% +$676 ﹤0.01% 1182
2022
Q4 		$15K Buy
268
+86
+47% +$4.38K ﹤0.01% 1221
2022
Q3 		$8K Buy
182
+13
+8% +$666 ﹤0.01% 1429
2022
Q2 		$9K Buy
169
+1
+0.6% +$60 ﹤0.01% 1305
2022
Q1 		$11K Buy
168
+13
+8% +$856 ﹤0.01% 1245
2021
Q4 		$10K Hold
155
– – ﹤0.01% 1266
2021
Q3 		$11K Hold
155
– – ﹤0.01% 959
2021
Q2 		$11K Hold
155
– – ﹤0.01% 1012
2021
Q1 		$11K Hold
155
– – ﹤0.01% 981
2020
Q4 		$10K Hold
155
– – ﹤0.01% 907
2020
Q3 		$7K Hold
155
– – ﹤0.01% 960
2020
Q2 		$7K Hold
155
– – ﹤0.01% 962
2020
Q1 		$7K Buy
155
+119
+331% +$6.25K ﹤0.01% 872
2019
Q4 		$2K Hold
36
– – ﹤0.01% 1290
2019
Q3 		$2K Hold
36
– – ﹤0.01% 1264
2019
Q2 		$2K Hold
36
– – ﹤0.01% 1232
2019
Q1 		$2K Hold
36
– – ﹤0.01% 1232
2018
Q4 		$1K Buy
+36
New +$1.98K ﹤0.01% 1265

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lindbrook Capital's IART Position: Q1 2025 in Review

Lindbrook Capital increased its Integra LifeSciences (IART) stake by 1.6% in Q1 2025, buying an estimated $306 and bringing the position to 819 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #1400.

Lindbrook Capital first reported a position in IART in Q4 2018 and has held it in 26 quarters since. The position peaked at $26.6K in Q2 2024. 219 funds tracked by Wall St. Rank hold IART as of Q1 2025.

  • Lindbrook Capital held 819 shares of Integra LifeSciences worth $18K as of Q1 2025.
  • Lindbrook Capital bought 13 Integra LifeSciences shares in Q1 2025, an estimated $306.
  • Integra LifeSciences made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1400 holding.
  • Lindbrook Capital first reported a position in Integra LifeSciences in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's Integra LifeSciences position peaked at $26.6K in Q2 2024.
  • 219 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.